Sung Lee
Director of Finance/CFO presso VIR BIOTECHNOLOGY, INC.
Patrimonio netto: 1 M $ in data 31/03/2024
Profilo
Sung H.
Lee is currently the Chief Financial Officer, Secretary & Executive VP at Vir Biotechnology, Inc. He previously held positions as Vice President-Investor Relations at Gilead Sciences, Inc. from 2005 to 2019, Chief Financial Officer & Executive Vice President at Sangamo Therapeutics, Inc. from 2019 to 2021, and Chief Financial Officer at MorphoSys AG from 2021 to 2023.
Mr. Lee holds a graduate degree from the University of Southern California and an undergraduate degree from the University of California, Irvine.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
VIR BIOTECHNOLOGY, INC.
0.07% | 27/03/2024 | 100 492 ( 0.07% ) | 1 M $ | 31/03/2024 |
Posizioni attive di Sung Lee
| Società | Posizione | Inizio |
|---|---|---|
| VIR BIOTECHNOLOGY, INC. | Director of Finance/CFO | 27/03/2023 |
Precedenti posizioni note di Sung Lee
| Società | Posizione | Fine |
|---|---|---|
| MORPHOSYS AG | Director of Finance/CFO | 17/03/2023 |
| SANGAMO THERAPEUTICS, INC. | Director of Finance/CFO | 01/02/2021 |
| GILEAD SCIENCES, INC. | Investor Relations Contact | 31/10/2019 |
Formazione di Sung Lee
| University of Southern California | Graduate Degree |
| University of California, Irvine | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 4 |
|---|---|
| GILEAD SCIENCES, INC. | Health Technology |
| SANGAMO THERAPEUTICS, INC. | Health Technology |
| MORPHOSYS AG | Health Technology |
| VIR BIOTECHNOLOGY, INC. | Health Technology |
- Borsa valori
- Insiders
- Sung Lee
